Behavioral and Gene Regulatory Responses to Developmental Drug Exposures in Zebrafish.

RNA-seq addiction amphetamine behavior developmental exposure nicotine oxycodone zebrafish

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2021
Historique:
received: 14 10 2021
accepted: 29 11 2021
entrez: 27 1 2022
pubmed: 28 1 2022
medline: 28 1 2022
Statut: epublish

Résumé

Developmental consequences of prenatal drug exposure have been reported in many human cohorts and animal studies. The long-lasting impact on the offspring-including motor and cognitive impairments, cranial and cardiac anomalies and increased prevalence of ADHD-is a socioeconomic burden worldwide. Identifying the molecular changes leading to developmental consequences could help ameliorate the deficits and limit the impact. In this study, we have used zebrafish, a well-established behavioral and genetic model with conserved drug response and reward pathways, to identify changes in behavior and cellular pathways in response to developmental exposure to amphetamine, nicotine or oxycodone. In the presence of the drug, exposed animals showed altered behavior, consistent with effects seen in mammalian systems, including impaired locomotion and altered habituation to acoustic startle. Differences in responses seen following acute and chronic exposure suggest adaptation to the presence of the drug. Transcriptomic analysis of exposed larvae revealed differential expression of numerous genes and alterations in many pathways, including those related to cell death, immunity and circadian rhythm regulation. Differential expression of circadian rhythm genes did not correlate with behavioral changes in the larvae, however, two of the circadian genes,

Identifiants

pubmed: 35082702
doi: 10.3389/fpsyt.2021.795175
pmc: PMC8785235
doi:

Types de publication

Journal Article

Langues

eng

Pagination

795175

Subventions

Organisme : NIDA NIH HHS
ID : U01 DA044400
Pays : United States

Informations de copyright

Copyright © 2022 Mech, Merteroglu, Sealy, Teh, White, Havelange, Brennan and Busch-Nentwich.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Mol Cancer. 2010 Feb 26;9:45
pubmed: 20187950
FEMS Immunol Med Microbiol. 2006 Aug;47(3):330-42
pubmed: 16872369
Eur Psychiatry. 2006 Apr;21(3):180-5
pubmed: 16632165
Sci Rep. 2017 Oct 4;7(1):12657
pubmed: 28978916
J Biol Chem. 2015 Feb 13;290(7):4367-82
pubmed: 25544291
Front Neurosci. 2015 Jan 12;8:445
pubmed: 25628526
Psychopharmacology (Berl). 2017 Jun;234(12):1853-1869
pubmed: 28332006
PLoS One. 2010 Feb 18;5(2):e9259
pubmed: 20174623
J Neurosci. 2002 Dec 15;22(24):10731-41
pubmed: 12486166
PLoS One. 2016 May 02;11(5):e0154836
pubmed: 27136348
Exp Neurol. 2011 Nov;232(1):22-32
pubmed: 21820432
Pediatr Res. 2008 Nov;64(5):470-6
pubmed: 18679162
Brain Behav Immun. 2011 Jun;25 Suppl 1:S4-S12
pubmed: 21402143
Neuropharmacology. 1999 Aug;38(8):1207-23
pubmed: 10462133
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
PLoS One. 2020 Aug 7;15(8):e0237167
pubmed: 32764780
J Hazard Mater. 2012 Nov 15;239-240:19-23
pubmed: 22572562
Arch Gen Psychiatry. 2004 Aug;61(8):836-43
pubmed: 15289282
PLoS One. 2012;7(12):e49897
pubmed: 23227154
Dev Pharmacol Ther. 1985;8(6):384-95
pubmed: 4075937
Pediatrics. 2008 Jul;122(1):e83-91
pubmed: 18541617
Toxicol Appl Pharmacol. 2021 May 15;419:115483
pubmed: 33722667
Psychopharmacology (Berl). 2002 Feb;160(1):9-18
pubmed: 11862369
Alcohol Clin Exp Res. 2009 Dec;33(12):2147-53
pubmed: 19764937
J Exp Biol. 2008 May;211(Pt 10):1623-34
pubmed: 18456890
Dev Neurobiol. 2012 Mar;72(3):366-72
pubmed: 22328273
Addiction. 1994 Apr;89(4):455-62
pubmed: 8025504
Addict Biol. 2016 Jan;21(1):49-60
pubmed: 25138642
Neurosci Lett. 2007 Oct 29;427(1):66-70
pubmed: 17920769
Neuropharmacology. 2008 Mar;54(3):605-12
pubmed: 18164041
PeerJ. 2019 Feb 28;7:e6551
pubmed: 30842911
Early Hum Dev. 2008 Jan;84(1):29-35
pubmed: 17728081
Genes Brain Behav. 2006 Mar;5(2):150-7
pubmed: 16507006
Alcohol Res. 2012;34(3):355-61
pubmed: 23134052
Early Hum Dev. 2018 Jan;116:68-75
pubmed: 29195088
Front Neural Circuits. 2015 Aug 18;9:39
pubmed: 26347614
Neuropsychopharmacology. 2020 Apr;45(5):811-822
pubmed: 31905371
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11042-6
pubmed: 11572966
Nat Neurosci. 2001 Mar;4(3):289-96
pubmed: 11224546
Pediatrics. 2000 Mar;105(3):E40
pubmed: 10699142
Obstet Gynecol Clin North Am. 2014 Jun;41(2):177-89
pubmed: 24845483
Genome Biol. 2014;15(12):550
pubmed: 25516281
Curr Top Behav Neurosci. 2015;23:87-101
pubmed: 25655888
J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):910-2
pubmed: 26567261
Front Behav Neurosci. 2017 Mar 06;11:35
pubmed: 28321184
J Perinatol. 2012 Oct;32(10):737-47
pubmed: 22652562
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Dec 20;111:110334
pubmed: 33905756
BMC Neurosci. 2010 Aug 02;11:90
pubmed: 20678210
Behav Brain Res. 2009 Dec 14;205(1):38-44
pubmed: 19540270
Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3245-55
pubmed: 18640924
J Pain Symptom Manage. 2005 May;29(5 Suppl):S47-56
pubmed: 15907646
Mol Brain. 2011 Jul 07;4:29
pubmed: 21736737
Elife. 2017 Nov 16;6:
pubmed: 29144233
Physiol Behav. 2011 Oct 24;104(5):831-7
pubmed: 21839758
Pediatr Clin North Am. 2019 Apr;66(2):353-367
pubmed: 30819342
Sci Rep. 2015 Oct 16;5:15212
pubmed: 26471974
Arch Gen Psychiatry. 2003 Dec;60(12):1193-200
pubmed: 14662551
Annu Rev Pharmacol Toxicol. 2009;49:57-71
pubmed: 18834313
Clin Microbiol Rev. 2003 Apr;16(2):209-19
pubmed: 12692094
Psychopharmacology (Berl). 2007 Feb;190(3):269-319
pubmed: 16896961
PLoS Pathog. 2008 Feb 8;4(2):e28
pubmed: 18282092
Biol Psychiatry. 2010 Oct 15;68(8):748-54
pubmed: 20719303
J Pharmacol Exp Ther. 2017 Oct;363(1):66-79
pubmed: 28790193
Biom J. 2008 Jun;50(3):346-63
pubmed: 18481363
Nat Rev Neurosci. 2009 Apr;10(4):303-12
pubmed: 19277053
Behav Neurosci. 2014 Jun;128(3):387-412
pubmed: 24731209
PLoS One. 2007 Sep 26;2(9):e930
pubmed: 17895971
Curr Biol. 2008 May 6;18(9):678-83
pubmed: 18439826
Neuropharmacology. 2009;56 Suppl 1:91-6
pubmed: 18644396
Neuron. 2017 Sep 27;96(1):130-144.e6
pubmed: 28957664
Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6368-73
pubmed: 16618939
Front Neural Circuits. 2015 Aug 25;9:41
pubmed: 26379509
J Neurosci. 2010 Dec 1;30(48):16082-90
pubmed: 21123555
Front Psychiatry. 2011 Jun 28;2:38
pubmed: 21747770
Scand J Public Health. 2000 Jun;28(2):154-7
pubmed: 10954143
J Anal Toxicol. 1997 Oct;21(6):515-7
pubmed: 9323536
J Pharmacol Exp Ther. 2007 Feb;320(2):507-15
pubmed: 17068203
Am J Psychiatry. 2016 Aug 1;173(8):799-806
pubmed: 27216261
Elife. 2014 Sep 12;3:e03781
pubmed: 25217530
Front Neurosci. 2019 Aug 01;13:771
pubmed: 31417344
Genes Brain Behav. 2019 Feb;18(2):e12549
pubmed: 30588759
Hear Res. 2008 Nov;245(1-2):58-64
pubmed: 18801421
Biomolecules. 2021 Feb 19;11(2):
pubmed: 33669793
Brain Res. 2015 Dec 2;1628(Pt A):50-9
pubmed: 25301690
Psychopharmacology (Berl). 2009 May;203(4):771-80
pubmed: 19052727
Mol Cell Endocrinol. 2011 Mar 15;335(1):2-13
pubmed: 20398732
Neurotoxicology. 2021 Sep;86:172-179
pubmed: 34391795
J Neurosci. 2007 May 2;27(18):4984-94
pubmed: 17475807
Hum Mol Genet. 2008 Apr 1;17(7):963-70
pubmed: 18079108
Nat Protoc. 2008;3(1):59-69
pubmed: 18193022
Biol Psychiatry. 2006 Mar 15;59(6):536-45
pubmed: 16139819
PLoS One. 2013;8(2):e56108
pubmed: 23405257
Neurobiol Learn Mem. 2009 Sep;92(2):243-8
pubmed: 18644244
Neuropsychopharmacology. 2015 Jan;40(1):61-87
pubmed: 24938210
Am J Addict. 2009 Sep-Oct;18(5):430-7
pubmed: 19874164
Adv Neurobiol. 2020;24:143-162
pubmed: 32006359
Depress Anxiety. 2009;26(2):147-54
pubmed: 19105213
Dev Med Child Neurol. 2001 Oct;43(10):668-75
pubmed: 11665823
Life Sci. 2006 Nov 2;79(23):2221-7
pubmed: 16959275
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(3):415-26
pubmed: 1862221
Lancet. 2021 Mar 20;397(10279):1139-1150
pubmed: 33617769
Brain Res. 2005 Feb 9;1034(1-2):11-24
pubmed: 15713255
Nat Methods. 2012 Jun 17;9(7):735-42
pubmed: 22706672
Int J Cancer. 2013 May 1;132(9):2095-106
pubmed: 23034676
Brain Res Dev Brain Res. 2000 Dec 29;125(1-2):9-19
pubmed: 11154756
Transl Psychiatry. 2012 Mar 06;2:e86
pubmed: 22832851
J Vis Exp. 2006 Nov 13;(1):104
pubmed: 18704188
Addiction. 2011 Jan;106(1):170-7
pubmed: 20883457
Handb Clin Neurol. 2021;182:63-82
pubmed: 34266612
Med Hypotheses. 2004;63(6):1047-50
pubmed: 15504573
Nicotine Tob Res. 2011 May;13(5):301-12
pubmed: 21385906
Nucleic Acids Res. 2013 Jul;41(12):6161-74
pubmed: 23620290
Bioinformatics. 2019 Nov 08;:
pubmed: 31702788
Pharmacol Ther. 2014 Oct;144(1):50-9
pubmed: 24836728
Pediatrics. 2006 Sep;118(3):1149-56
pubmed: 16951010
Mol Neurobiol. 2021 Apr;58(4):1650-1663
pubmed: 33236326
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9377-81
pubmed: 15967985
Brain Sci. 2013 Sep 1;3(3):1153-81
pubmed: 24587895
Comput Struct Biotechnol J. 2021 Apr 19;19:2416-2422
pubmed: 34025933
Neurosci Res. 2014 Feb;79:41-51
pubmed: 24157430
J Biol Rhythms. 2002 Jun;17(3):202-9
pubmed: 12054191
Behav Neurosci. 2007 Dec;121(6):1342-52
pubmed: 18085887
Dev Cell. 2009 Dec;17(6):755-73
pubmed: 20059947
Fish Physiol Biochem. 2010 Dec;36(4):1199-215
pubmed: 20432063
Chronobiol Int. 2011 Nov;28(9):771-8
pubmed: 21895489
Am Fam Physician. 2003 Nov 15;68(10):1971-8
pubmed: 14655806
Front Mol Neurosci. 2011 May 17;4:6
pubmed: 21629823
J Neurosci. 2008 Jul 16;28(29):7344-9
pubmed: 18632938
Psychopharmacology (Berl). 2001 Apr;155(1):78-85
pubmed: 11374339
Acta Paediatr Suppl. 1994 Nov;404:27-31
pubmed: 7531039
Eur J Pharmacol. 2000 Oct 27;407(1-2):73-81
pubmed: 11050293
Psychopharmacology (Berl). 2021 Aug;238(8):2191-2200
pubmed: 33963883
Sci Pract Perspect. 2002 Jul;1(1):13-20
pubmed: 18567959
Bioinformatics. 2015 Sep 1;31(17):2912-4
pubmed: 25964631
Behav Brain Res. 2010 Dec 25;214(2):332-42
pubmed: 20540966
Brain Res Dev Brain Res. 2000 Aug 30;122(2):125-33
pubmed: 10960681
Rev Neurosci. 2018 Mar 28;29(3):283-294
pubmed: 29194045
Nat Med. 2005 Jan;11(1):35-42
pubmed: 15608650
Front Hum Neurosci. 2014 Mar 28;8:174
pubmed: 24734015
Elife. 2020 Mar 25;9:
pubmed: 32209227
Pediatr Clin North Am. 2019 Dec;66(6):1149-1161
pubmed: 31679604
Neurosci Biobehav Rev. 2005;29(4-5):627-47
pubmed: 15925697
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5359-64
pubmed: 19273846
Acta Pharmacol Sin. 2009 Jun;30(6):715-22
pubmed: 19448649

Auteurs

Aleksandra M Mech (AM)

School of Biological and Behavioural Sciences, Faculty of Science and Engineering, Queen Mary University of London, London, United Kingdom.

Munise Merteroglu (M)

Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom.

Ian M Sealy (IM)

Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom.

Muy-Teck Teh (MT)

Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, England, United Kingdom.

Richard J White (RJ)

Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom.

William Havelange (W)

School of Biological and Behavioural Sciences, Faculty of Science and Engineering, Queen Mary University of London, London, United Kingdom.

Caroline H Brennan (CH)

School of Biological and Behavioural Sciences, Faculty of Science and Engineering, Queen Mary University of London, London, United Kingdom.

Elisabeth M Busch-Nentwich (EM)

School of Biological and Behavioural Sciences, Faculty of Science and Engineering, Queen Mary University of London, London, United Kingdom.
Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom.

Classifications MeSH